Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 21 05:30

Express News | Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 21 05:30

Wells Fargo Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Raises Target Price to $88

Futu NewsDec 21 03:35 · Ratings

Wells Fargo Remains a Buy on Ultragenyx Pharmaceutical (RARE)

TipRanksDec 21 02:39 · Ratings

Evercore Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $70

Futu NewsDec 21 02:31 · Ratings

Wells Fargo Maintains Overweight on Ultragenyx Pharmaceutical, Raises Price Target to $88

BenzingaDec 20 21:38 · Ratings